Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/9660
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Christou, G. A. | en |
dc.contributor.author | Tselepis, A. D. | en |
dc.contributor.author | Kiortsis, D. N. | en |
dc.date.accessioned | 2015-11-24T16:50:56Z | - |
dc.date.available | 2015-11-24T16:50:56Z | - |
dc.identifier.issn | 0018-5043 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/9660 | - |
dc.rights | Default Licence | - |
dc.subject | insulin resistance | en |
dc.subject | lipid metabolism | en |
dc.subject | adipose tissue | en |
dc.subject | metabolic syndrome | en |
dc.subject | adipokines | en |
dc.subject | atherosclerosis | en |
dc.subject | density-lipoprotein cholesterol | en |
dc.subject | type-2 diabetes-mellitus | en |
dc.subject | fatty liver-disease | en |
dc.subject | serum retinol-binding-protein-4 levels | en |
dc.subject | primary human adipocytes | en |
dc.subject | morbidly obese subjects | en |
dc.subject | insulin-resistance | en |
dc.subject | adipose-tissue | en |
dc.subject | weight-loss | en |
dc.subject | vitamin-a | en |
dc.title | The Metabolic Role of Retinol Binding Protein 4: An Update | en |
heal.type | journalArticle | - |
heal.type.en | Journal article | en |
heal.type.el | Άρθρο Περιοδικού | el |
heal.identifier.primary | DOI 10.1055/s-0031-1295491 | - |
heal.identifier.secondary | <Go to ISI>://000298698600002 | - |
heal.identifier.secondary | https://www.thieme-connect.de/DOI/DOI?10.1055/s-0031-1295491 | - |
heal.identifier.secondary | https://www.thieme-connect.de/ejournals/pdf/10.1055/s-0031-1295491.pdf | - |
heal.language | en | - |
heal.access | campus | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Θετικών Επιστημών. Τμήμα Χημείας | el |
heal.publicationDate | 2012 | - |
heal.abstract | Retinol binding protein 4 (RBP(4)) is regarded as a novel cardiometabolic risk factor, which is secreted mainly by the hepatocytes and also by the adipose tissue. RBP(4) has been shown to induce insulin resistance, and plasma RBP(4) values are increased in type 2 diabetes mellitus, obesity, metabolic syndrome, and cardiovascular disease. Moreover, it has been found that circulating RBP(4) decreases during medical interventions that result in amelioration of the metabolic profile, such as diet, exercise, oral antidiabetic drugs, and hypolipidemic agents. However, only few of the RBP(4)-related studies have investigated whether RBP(4) constitutes a causal factor of the above-mentioned metabolic conditions. Importantly, circulating RBP(4) is influenced by some nonmetabolic conditions, such as renal failure, acute illness, injury, and liver failure. Thus, further studies investigating the metabolic roles of RBP(4) should be carefully planned, taking into account the effects of nonmetabolic conditions on circulating RBP(4). | en |
heal.journalName | Hormone and Metabolic Research | en |
heal.journalType | peer reviewed | - |
heal.fullTextAvailability | TRUE | - |
Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά). ΧΗΜ |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Christou-2012-The Metabolic Role o.pdf | 247.34 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License